PPARGC1A and metabolic dysfunction-associated steatotic liver disease: This study used FFA to induce the formation of a NAFLD cell model, the lipid accumulation of PGC-1α intervention group is reduced by enhancing mitochondrial biosynthesis, ATP generation, fatty acid oxidation and decomposition.